Moleculin Biotech Inc. (MBRX)
MBRX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.4352
+5.15% on the day
Market cap
$8.9M
Nano cap
Revenue · 2025
$0
Prior year not contiguous
Net income · 2025
$33.6M
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | MBRX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2016 |
| SEC CIK | 0001659617 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $0 |
| Net income | $33.6M |
| Operating income | -$25.1M |
| Net margin | Needs revenue and net income |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | $8.9M |
| Total assets | $22.1M |
| P/E (computed) | 0.3× |
| P/S (computed) | Needs market cap and revenue |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B5 | 424B5 | 2026-08-21 |
| Latest annual report FORM 10-K/A | 10-K/A | 2026-04-14 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-13 |
| Latest current report FORM 8-K | 8-K | 2026-10-09 |
| Latest proxy FORM DEFA14A | DEFA14A | 2026-08-24 |
Source: SEC EDGAR submissions feed, 830 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CMMB | Chemomab Therapeutics Ltd. American Depositary Share | $1.24 | -10.79% | $9.0M |
| ADIL | Adial Pharmaceuticals Inc | $3.29 | -6.00% | $8.6M |
| IMRN | Immuron Limited | $1.04 | 0.00% | $8.4M |
| MTVA | MetaVia Inc. | $1.43 | -1.38% | $9.4M |
| VTGN | Vistagen Therapeutics Inc. | $0.2148 | -5.21% | $9.5M |
| BOLT | Bolt Biotherapeutics Inc. | $4.29 | +1.06% | $8.3M |
| KPTI | Karyopharm Therapeutics Inc. | $0.4274 | -15.38% | $9.7M |
| TOVX | Theriva Biologics Inc. | $0.2157 | -1.69% | $9.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier